Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 4572.00 | 4603.75 | 0.9931 | 0.9852 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4654.00 | 4603.75 | 1.0109 | 1.0235 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4642.00 | 4603.75 | 1.0083 | 1.0179 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4975.00 | 4603.75 | 1.0806 | 1.1742 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4297.00 | 4603.75 | 0.9334 | 0.8569 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4791.00 | 4603.75 | 1.0407 | 1.0877 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4481.00 | 4603.75 | 0.9733 | 0.9426 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4689.00 | 4603.75 | 1.0185 | 1.0399 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4391.00 | 4603.75 | 0.9538 | 0.9007 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4742.00 | 4603.75 | 1.0300 | 1.0648 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 2500.00 | 2418.67 | 3955.00 | 4603.75 | 0.8591 | 0.6982 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4249.00 | 4603.75 | 0.9229 | 0.8345 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 2500.00 | 2418.67 | 4655.00 | 4603.75 | 1.0111 | 1.0240 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4595.00 | 4603.75 | 0.9981 | 0.9959 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4369.00 | 4603.75 | 0.9490 | 0.8904 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4308.00 | 4603.75 | 0.9358 | 0.8620 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 3960.00 | 4603.75 | 0.8602 | 0.7005 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4303.00 | 4603.75 | 0.9347 | 0.8597 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4462.00 | 4603.75 | 0.9692 | 0.9338 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 2866.00 | 4603.75 | 0.6225 | 0.2005 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4615.00 | 4603.75 | 1.0024 | 1.0053 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4446.00 | 4603.75 | 0.9657 | 0.9263 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4721.00 | 4603.75 | 1.0255 | 1.0549 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 2125.00 | 4603.75 | 0.4616 | -0.1301 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4959.00 | 4603.75 | 1.0772 | 1.1667 |